Biofeedback and other therapies for the treatment of urinary incontinence in the elderly

Alternative Medicine Review

Volumn 11, Issue 3, 2006, Pages 224-231

  Cherniack, E Paul ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUZHONGYIQITANG; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; OXYBUTYNIN; PLANT EXTRACT; PYGEUM AFRICANUM EXTRACT; ROYSTONEA REGIA EXTRACT; SABAL EXTRACT; TOLTERODINE; UNCLASSIFIED DRUG; URTICA DIOICA EXTRACT;

ACUPUNCTURE; AGING; ALTERNATIVE MEDICINE; CHINESE MEDICINE; CLINICAL TRIAL; DISEASE CLASSIFICATION; FEEDBACK SYSTEM; HERBAL MEDICINE; HUMAN; HYPNOSIS; NONHUMAN; OVERFLOW INCONTINENCE; PATHOPHYSIOLOGY; PATIENT SELECTION; PELVIC FLOOR MUSCLE TRAINING; REVIEW; SAMPLE SIZE; STANDARDIZATION; STRESS INCONTINENCE; URGE INCONTINENCE; URINE INCONTINENCE;

AGED; BIOFEEDBACK (PSYCHOLOGY); COMPLEMENTARY THERAPIES; FEMALE; HUMANS; MALE; URINARY INCONTINENCE; URINARY INCONTINENCE, STRESS;

EID: 33749563311     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. DeBeau CE. Urinary incontinence. In: Pompei P, Murphy JB, eds. Geriatric Review Syllabus. 6th ed. Oxford, UK: Blackwell; 2006:184-195.
2. Norton P, Brubaker L. Urinary incontinence in women. Lancet 2006;367:57-67.
3. Wein AJ, Rackley RR. Overactive bladder: a better understanding of pathophysiology, diagnosis, and management. J Urol 2006;175:S5-S10.
4. Johnson TM 2nd, Ouslander JG. Urinary incontinence in the older man. Med Clin North Am 1999;83:1247-1266.
5. Alivizatos G, Skolarikos A. Incontinence and erectile dysfunction following radical prostatectomy: a review. Scientific World Journal 2005;5:747-758.
6. Cornel EB, de Wit R, Witjes JA. Evaluation of early pelvic floor physiotherapy on the duration and degree of urinary incontinence after radical retropubic prostatectomy in a non-teaching hospital. World J Urol 2005;23:353-355.
7. Filocamo MT, Li Marzi V, Del Popolo G, et al. Effectiveness of early pelvic floor rehabilitation treatment for post-prostatectomy incontinence. Eur Urol 2005;48:734-738.
8. Pannek J, Konig JE. Clinical usefulness of pelvic floor reeducation for men undergoing radical prostatectomy. Urol Int 2005;74:38-43.
9. Stern JA, Clemens JQ, Tiplitsky SI, et al. Long-term results of the bulbourethral sling procedure. J Urol 2005;173:1654-1656.
10. Moore KN, Griffiths D, Hughton A. Urinary incontinence after radical prostatectomy: a randomized controlled trial comparing pelvic muscle exercises with or without electrical stimulation. BJU Int 1999;83:57-65.
11. Hubner WA, Schlarp OM. Treatment of incontinence after prostatectomy using a new minimally invasive device: adjustable continence therapy. BJU Int 2005;96:587-594.
12. Castle EP, Andrews PE, Itano N, et al. The male sling for post-prostatectomy incontinence: mean followup of 18 months. J Urol 2005;173:1657-1660.
13. Gnessin E, Livne PM, Baniel J, Gillon G. Continence and quality of life assessment after artificial urinary sphincter implantation. Isr Med Assoc J 2004;6:592-594.
14. Jones JS, Vasavada SP, Abdelmalak JB, et al. Sling may hasten return of continence after radical prostatectomy. Urology 2005;65:1163-1167.
15. John H. Bulbourethral composite suspension: a new operative technique for post-prostatectomy incontinence. J Urol 2004;171:1866-1870.
16. McConnell JD, Roehrborn CG, Bautista OM, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Eng J Med 2003;349:2387-2398.
17. Wasson JH, Reda DJ, Brusekwitz RC, et al. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med 1995;332:75-79.
18. Weinberger MW, Goodman BM, Carnes M. Long-term efficacy of nonsurgical urinary incontinence treatment in elderly women. J Gerontol A Biol Sci Med Sci 1999;54:M117-M121.
19. Doggweiler-Wiygul R, Sellhorn E. Role of behavioral changes and biofeedback in urology. World J Urol 2002;20:302-305.
20. Holmes DM, Plevnik S, Stanton SL. Bladder neck electrical conductivity in the treatment of detrusor instability with biofeedback. Br J Obstet Gynaecol 1989;96:821-826.
21. Cardozo L, Stanton SL, Hafner J, Allan V. Biofeedback in the treatment of detrusor instability. Br J Urol 1978;50:250-254.
22. Cardozo LD. Biofeedback in overactive bladder. Urology 2000;55:S24-S28.
23. Wang AC, Wang YY, Chen MC. Single-blind, randomized trial of pelvic floor muscle training, biofeedback-assisted pelvic floor muscle training, and electrical stimulation in the management of overactive bladder. Urology 2004;63:61-66.
24. Wang AC. Bladder-sphincter biofeedback as treatment of detrusor instability in women who failed to respond to oxybutynin. Chang Gung Med J 2000;23:590-599.
25. Pages IH, Jahr S, Schaufele MK, Conradi E. Comparative analysis of biofeedback and physical therapy for treatment of urinary stress incontinence in women. Am J Phys Med Rehabil 2001;80:494-502.
26. Burns PA, Pranikoff K, Nochajski TH, et al. A comparison of effectiveness of biofeedback and pelvic muscle exercise treatment of stress incontinence in older community-dwelling women. J Gerontol 1993;48:M167-M174.
27. Aukee P, Immonen P, Laaksonen D, et al. The effect of home biofeedback training on stress incontinence. Acta Obstet Gynecol Scand 2004;83:973-977.
28. Gordon D, Luxman D, Sarig Y, Groutz A. Pelvic floor exercise and biofeedback in women with urinary stress incontinence. Harefuah 1999;136:593-596,660. [Article in Hebrew]
29. Pena Outeirino JM, Leon Duenas E, Romero Gil JR, et al. Unstable detrusor: usefulness of biofeedback. Actas Urol Esp 1996;20:640-647. [Article in Spanish]
30. Sung MS, Hong JY, Choi YH, et al. FES-biofeedback versus intensive pelvic floor muscle exercise for the prevention and treatment of genuine stress incontinence. J Korean Med Sci 2000;15:303-308.
31. Morkved S, Bo K, Fjortoft T. Effect of adding biofeedback to pelvic floor muscle training to treat urodynamic stress incontinence. Obstet Gynecol 2002;100:730-739.
32. Berghmans LC, Frederiks CM, de Bie RA, et al. Efficacy of biofeedback, when included with pelvic floor muscle exercise treatment, for genuine stress incontinence. Neurourol Urodyn 1996;15:37-52.
33. Berghmans LC, Hendriks HJ, Bo K, et al. Conservative treatment of stress urinary incontinence in women: a systematic review of randomized controlled trials. Br J Urol 1998;82:181-191.
34. Weatherall M. Biofeedback or pelvic floor muscle exercises for female genuine stress incontinence: a meta-analysis of trials identified in a systematic review. BJU Int 1999;83:1015-1016.
35. Van Kampen M, De Weerdt W, Van Poppel H, et al. Effect of pelvic-floor re-education on duration and degree of incontinence after radical prostatectomy: a randomised controlled trial. Lancet 2000;355:98-102.
36. Mathewson-Chapman M. Pelvic muscle exercise/biofeedback for urinary incontinence after prostatectomy: an education program. J Cancer Educ 1997;12:218-223.
37. Parekh AR, Feng MI, Kirages D, et al. The role of pelvic floor exercises on post-prostatectomy incontinence. J Urol 2003;170:130-133.
38. Fanciullacci F, Franzini A, Politi P, et al. Continence problems after radical prostatectomy: role of rehabilitation of the pelvic floor. Arch Ital Urol Androl 2001;73:153-156. [Article in Italian]
39. Burgio KL, Stutzman RE, Engel BT. Behavioral training for post-prostatectomy urinary incontinence. J Urol 1989;141:303-306.
40. Franke JJ, Gilbert WB, Grier J, et al. Early post-prostatectomy pelvic floor biofeedback. J Urol 2000;163:191-193.
41. Wille S, Sobottka A, Heidenreich A, Hofmann R. Pelvic floor exercises, electrical stimulation and biofeedback after radical prostatectomy: results of a prospective randomized trial. J Urol 2003;170:490-493.
42. Sueppel C, Kreder K, See W. Improved continence outcomes with preoperative pelvic floor muscle strengthening exercises. Urol Nurs 2001;21:201-210.
43. Marsh DW, Lepor H. Predicting continence following radical prostatectomy. Curr Urol Rep 2001;2:248-252.
44. Hunter KF, Moore KN, Cody DJ, Glazener CM. Conservative management for postprostatectomy urinary incontinence. Cochrane Database Syst Rev 2004;2:CD001843.
45. Jundt K, Peschers UM, Dimpfl T. Long-term efficacy of pelvic floor re-education with EMG-controlled biofeedback. Eur J Obstet Gynecol Reprod Biol 2002;105:181-185.
46. Stein M, Discippio W, Davia M, Taub H. Biofeedback for the treatment of stress and urge incontinence. J Urol 1995;153:641-643.
47. Susset JG, Galea G, Read L. Biofeedback therapy for female incontinence due to low urethral resistance. J Urol 1990;143:1205-1208.
48. Burgio KL, Robinson JC, Engel BT. The role of biofeedback in Kegel exercise training for stress urinary incontinence. Am J Obstet Gynecol 1986;154:58-64.
49. Hirsch A, Weirauch G, Steimer B, et al. Treatment of female urinary incontinence with EMG-controlled biofeedback home training. Int Urogynecol J Pelvic Floor Dysfunct 1999;10:7-10.
50. Burgio KL, Locher JL, Goode PS, et al. Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial. JAMA 1998;280:1995-2000.
51. Johnson TM 2nd, Burgio KL, Redden DT, et al. Effects of behavioral and drug therapy on nocturia in older incontinent women. J Am Geriatr Soc 2005;53:846-850.
52. Freeman RM, Baxby K. Hypnotherapy for incontinence caused by the unstable detrusor. Br Med J (Clin Res Ed) 1982;284:1831-1834.
53. Honjo H, Naya Y, Ukimura O, et al. Acupuncture on clinical symptoms and urodynamic measurements in spinal-cord-injured patients with detrusor hyperreflexia. Urol Int 2000;65:190-195.
54. Emmons SL, Otto L. Acupuncture for overactive bladder: a randomized controlled trial. Obstet Gynecol 2005;106:138-143.
55. Kitakoji H, Terasaki T, Honjo H, et al. Effect of acupuncture on the overactive bladder. Nippon Hinyokika Gakkai Zasshi 1995;86:1514-1519. [Article in Japanese]
56. Philp T, Shah PJ, Worth PH. Acupuncture in the treatment of bladder instability. Br J Urol 1988;61:490-493.
57. Murakami Y. Clinical effect of hotyuekkito (buzhongyiqitang) on symptoms due to renal ptosis and stress incontinence. Hinyokika Kiyo 1988;34:1841-1843. [Article in Japanese]
58. Alsikafi NF, Gerber GS. The use of phytotherapy in the treatment of men with benign prostatic hyperplasia. In: Cherniack EP, Cherniack NS, eds. Alternative Medicine for the Elderly. Berlin, Germany: Springer Verlag: 2003:399-410.
59. Bracher F. Phytotherapy of benign prostatic hyperplasia. Urologe A 1997;36:10-17. [Article in German]
60. Madersbacher S, Schatzl G, Brossner C, Dreikorn K. Phytotherapy for BPS. Which products can still be prescribed? Urologe A 2005;44:513-520. [Article in German]
61. Buck AC. Is there a scientific basis for the therapeutic effects of Serenoa repens in benign prostatic hyperplasia? Mechanisms of action. J Urol 2004;172:1792-1799.
62. Gong EM, Gerber GS. Saw palmetto and benign prostatic hyperplasia. Am J Chin Med 2004;32:331-338.
63. Wilt TJ, Ishani A, Rutks I, MacDonald R. Phytotherapy for benign prostatic hyperplasia. Public Health Nutr 2000;3:459-472.
64. Wilt TJ, Ishani A, Stark G, et al. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. JAMA 1998;280:1604-1609.
65. Gerber GS. Phytotherapy for benign prostatic hyperplasia. Curr Urol Rep 2002;3:285-291.
66. Gerber GS, Fitzpatrick JM. The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia. BJU Int 2004;94:338-344.
67. Marks LS, Partin AW, Epstein JI, et al. Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia. J Urol 2000;163:1451-1456.
68. Habib FK, Wyllie MG. Not all brands are created equal: a comparison of selected components of different brands of Serenoa repens extract. Prostate Cancer Prostatic Dis 2004;7:195-200.
69. Gerber GS, Zagaja GP, Bales GT, et al. Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms. Urology 1998;51:1003-1007.
70. Zlotta AR, Teillac P, Raynaud JP, Schulman CC. Evaluation of male sexual function in patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon), Tamsulosin or Finasteride. Eur Urol 2005;48:269-276.
71. Willetts KE, Clements MS, Champion S, et al. Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial. BJU Int 2003;92:267-270.
72. Al-Shukri SH, Deschaseaux P, Kuzmin IV, Amdiy RR. Early urodynamic effects of the lipido-sterolic extract of Serenoa repens (Permixon®) in patients with lower urinary tract symptoms due to benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 2000;3:195-199.
73. Pytel YA, Vinarov A, Lopatkin N, et al. Long-term clinical and biologic effects of the lipidosterolic extract of Serenoa repens in patients with symptomatic benign prostatic hyperplasia. Adv Ther 2002;19:297-306.
74. Wilt T, Ishani A, MacDonald R, et al. Pygeum africanum for benign prostatic hyperplasia. Cochrane Database Syst Rev 2002;(1):CD001044.
75. Katz AE. Flavonoid and botanical approaches to prostate health. J Altern Complement Med 2002;8:813-821.
76. Sokeland J. Combined sabal and Urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome. BJU Int 2000;86:439-442.
77. Preuss HG, Marcusen C, Regan J, et al. Randomized trial of a combination of natural products (cernitin, saw palmetto, β-sitosterol, vitamin E) on symptoms of benign prostatic hyperplasia (BPH). Int Urol Nephrol 2001;33:217-225.
78. Melo EA, Bertero EB, Rios LA, Mattos D Jr. Evaluating the efficiency of a combination of Pygeum africanum and stinging nettle (Urtica dioica) extracts in treating benign prostatic hyperplasia (BPH): double-blind, randomized, placebo controlled trial. Int Braz J Urol 2002;28:418-425.
79. Capasso R, Borrelli F, Capasso F, et al. Inhibitory effect of the antidepressant St. John's wort (Hypericum perforatum) on rat bladder contractility in vitro. Urology 2004;64:168-172.
80. Arruzazabala ML, Carbajal D, Mas R, et al. Preventive effects of D-004, a lipid extract from Cuban royal palm (Roystonea regia) fruits, on testosterone-induced prostate hyperplasia in intact and castrated rodents. Drugs Exp Clin Res 2004;30:227-233.
81. Ripoll E, Mahowald D. Hatha yoga therapy management of urologic disorders. World J Urol 2002;20:306-309.